Vertex Pharmaceuticals Incorporated (VRTX)

Vertex Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 27, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	113,325	103,707	104,849	74,127	55,834	61,457
Market Cap Growth	15.30%	-1.09%	41.44%	32.76%	-9.15%	9.16%
Enterprise Value	103,616	94,253	91,965	65,181	49,750	55,853
Last Close Price	448.40	402.70	406.89	288.78	219.60	236.34
PE Ratio	-	-	28.97	22.31	23.84	22.66
Forward PE	23.76	22.66	24.44	18.83	16.42	21.78
PS Ratio	10.41	9.41	10.62	8.30	7.37	9.90
PB Ratio	6.98	6.32	5.96	5.33	5.53	7.08
P/TBV Ratio	7.57	7.15	6.70	6.07	6.42	8.44
P/FCF Ratio	-	-	31.42	18.89	23.18	20.53
P/OCF Ratio	-	-	29.64	17.95	21.12	18.89
PEG Ratio	-	1.21	1.92	0.58	1.62	1.06
EV/Sales Ratio	9.34	8.55	9.32	7.30	6.57	9.00
EV/EBITDA Ratio	22.60	19.74	20.54	14.40	12.38	17.66
EV/EBIT Ratio	23.51	20.52	21.35	14.89	12.78	18.29
EV/FCF Ratio	-	-	27.56	16.61	20.66	18.66
Debt / Equity Ratio	0.10	0.11	0.05	0.07	0.10	0.11
Debt / EBITDA Ratio	0.35	0.36	0.18	0.20	0.24	0.30
Debt / FCF Ratio	-	-	0.24	0.23	0.40	0.32
Asset Turnover	0.47	0.49	0.48	0.57	0.60	0.62
Inventory Turnover	4.79	5.14	7.38	8.87	8.97	10.62
Quick Ratio	2.12	2.17	3.60	4.46	4.04	4.02
Current Ratio	2.65	2.69	3.99	4.83	4.46	4.33
Return on Equity (ROE)	-5.64%	-3.15%	22.99%	27.67%	24.93%	36.71%
Return on Assets (ROA)	11.77%	12.68%	13.17%	17.33%	19.32%	19.02%
Return on Capital (ROIC)	14.73%	15.71%	16.22%	21.15%	23.51%	23.29%
Return on Capital Employed (ROCE)	23.10%	24.20%	22.50%	28.40%	34.50%	30.90%
Earnings Yield	-0.87%	-0.52%	3.45%	4.48%	4.20%	4.41%
FCF Yield	-1.10%	-0.76%	3.18%	5.29%	4.31%	4.87%
Buyback Yield / Dilution	1.20%	1.00%	-0.54%	0.31%	1.33%	-1.04%

Updated May 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q